Precipio, Inc. financial data

Symbol
PRPO on Nasdaq
Industry
Laboratory Analytical Instruments
Location
12325 Emmet St, Omaha, NE
State of incorporation
DE
Fiscal year end
December 31
Former names
TRANSGENOMIC INC (to 6/30/2017)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 83 % -14%
Quick Ratio 13.9 % +8.94%
Debt-to-equity 36.6 % +30.9%
Operating Margin -27.2 % +60.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.48M shares +4.38%
Common Stock, Shares, Outstanding 1.48M shares +7.36%
Entity Public Float 10.4M USD -55.4%
Common Stock, Value, Issued 15K USD +7.14%
Weighted Average Number of Shares Outstanding, Basic 1.48M shares +6.14%
Weighted Average Number of Shares Outstanding, Diluted 1.48M shares +6.14%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 17.4M USD +31.3%
Revenue from Contract with Customer, Excluding Assessed Tax 17.6M USD +29.7%
Operating Income (Loss) -4.73M USD +47.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3M USD +66.9%
Income Tax Expense (Benefit) 0 USD
Earnings Per Share, Basic -1.69 USD/shares +87.2%
Earnings Per Share, Diluted -1.69 USD/shares +87.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.05M USD -32.6%
Accounts Receivable, after Allowance for Credit Loss, Current 1.02M USD -31.2%
Inventory, Net 590K USD -7.23%
Other Assets, Current 591K USD -5.89%
Assets, Current 3.26M USD -24.5%
Property, Plant and Equipment, Net 753K USD +2.03%
Operating Lease, Right-of-Use Asset 447K USD -33.1%
Intangible Assets, Net (Excluding Goodwill) 12.1M USD -7.28%
Other Assets, Noncurrent 48K USD -45.5%
Assets 17M USD -11%
Accounts Payable, Current 701K USD -72.1%
Employee-related Liabilities, Current 929K USD +9.81%
Accrued Liabilities, Current 2.74M USD +23.9%
Contract with Customer, Liability, Current 282K USD +872%
Liabilities, Current 4.48M USD -17.9%
Operating Lease, Liability, Noncurrent 254K USD -44.7%
Liabilities 5.01M USD -17.3%
Retained Earnings (Accumulated Deficit) -102M USD -3.03%
Stockholders' Equity Attributable to Parent 14.4M USD -11.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.9M USD -8.13%
Liabilities and Equity 17M USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -667K USD +57.7%
Net Cash Provided by (Used in) Financing Activities -59K USD -120%
Net Cash Provided by (Used in) Investing Activities -22K USD -120%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 1.48M shares +7.36%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -726K USD +44.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.05M USD -32.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9K USD -10%
Deferred Tax Assets, Valuation Allowance 19.9M USD +7.36%
Deferred Tax Assets, Gross 21.8M USD +4.79%
Operating Lease, Liability 459K USD -32.6%
Payments to Acquire Property, Plant, and Equipment 22K USD +120%
Lessee, Operating Lease, Liability, to be Paid 498K USD -34.8%
Property, Plant and Equipment, Gross 2.12M USD +6.92%
Operating Lease, Liability, Current 205K USD -7.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two 214K USD -4.46%
Lessee, Operating Lease, Liability, to be Paid, Year One 224K USD -13.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39K USD -53%
Lessee, Operating Lease, Liability, to be Paid, Year Three 214K USD +4.39%
Preferred Stock, Shares Issued 47 shares 0%
Preferred Stock, Shares Authorized 15M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 195K USD 0%
Operating Lease, Payments 100K USD 0%
Additional Paid in Capital 114M USD +1.79%
Preferred Stock, Shares Outstanding 47 shares 0%
Depreciation, Depletion and Amortization 304K USD -1.94%
Deferred Tax Assets, Net of Valuation Allowance 19.9M USD +6.99%
Share-based Payment Arrangement, Expense 1.4M USD -17.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%